Prima Biomed Ltd. (PRR.AX)


ASX - ASX Delayed Price. Currency in AUD
0.04+0.00 (+2.63%)
As of 12:14 AM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.04
Prev Close0.04
Bid0.04 x
Ask0.04 x
Day's Range0.04 - 0.04
52wk Range0.04 - 0.07
1y Target EstN/A
Market Cap80.4M
P/E Ratio (ttm)-0.93
BetaN/A
Volume1,532,244
Avg Vol (3m)1,465,976
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Marketwired5 hours ago

    European Patent Grants for IMP731 Antibody

    Prima BioMed Ltd announces the granting of patent number 2142210 entitled "Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune ...

  • Marketwired7 days ago

    Prima BioMed Ltd: Operational Update

    Prima BioMed Ltd , has provided an update on the Company's cash position and the recruitment progress in its two active clinical trials in IMP321.

  • Marketwired15 days ago

    Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency

    Prima BioMed Ltd , has received notification from the Listing Qualifications Department of The NASDAQ Stock Market indicating that, for the period from June 24, 2016 through August 5, 2016, the closing ...